Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 25, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 7X91 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with an Fv-clasp form of a human neutralizing antibody Ab496 | |
| 7X91 | 7X91 | The SARS-CoV-2 receptor binding domain bound with an Fv-clasp form of a human neutralizing antibody Ab496 | |
| 7X8Y | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab159 | |
| 7X8Y | 7X8Y | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab159 | |
| 7X8Z | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab188 | |
| 7X8Z | 7X8Z | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab188 | |
| 7X90 | 7X90 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326 | |
| 7X90 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326 | |
| 7X8W | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab354 | |
| 7X8W | 7X8W | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab354 | |
| 7X92 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab445 | |
| 7X92 | 7X92 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab445 | |
| 7X95 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab709 | |
| 7X95 | 7X95 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab709 | |
| 7X94 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712 | |
| 7X94 | 7X94 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712 | |
| 7X93 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765 | |
| 7X93 | 7X93 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765 | |
| 7Y6N | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab803 | |
| 7Y6N | 7Y6N | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab803 | |
| 7Y6L | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab816 | |
| 7Y6L | 7Y6L | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab816 | |
| 7X96 | P0DTC2 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab847 | |
| 7X96 | 7X96 | The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab847 | |
| 7R4R | P0DTC2 | The SARS-CoV-2 spike in complex with the 1.10 neutralizing nanobody | |
| 7R4R | 7R4R | The SARS-CoV-2 spike in complex with the 1.10 neutralizing nanobody | |
| 7R4Q | P0DTC2 | The SARS-CoV-2 spike in complex with the 1.29 neutralizing nanobody | |
| 7R4Q | 7R4Q | The SARS-CoV-2 spike in complex with the 1.29 neutralizing nanobody | |
| 7R4I | P0DTC2 | The SARS-CoV-2 spike in complex with the 2.15 neutralizing nanobody | |
| 7R4I | 7R4I | The SARS-CoV-2 spike in complex with the 2.15 neutralizing nanobody | |
| 9C20 | A0A0H2YT71 | The Sialidase NanJ in complex with Neu5,9Ac | |
| 1PTH | A29947 | The Structural Basis of Aspirin Activity Inferred from the Crystal Structure of Inactivated Prostaglandin H2 Synthase | PROSTAGLANDIN H2 SYNTHASE-1, PROTOPORPHYRIN IX CONTAINING FE, 2-BROMOACETYL GROUP, 2-HYDROXYBENZOIC ACID |
| 5BV9 | A8FDC4 | The Structure of Bacillus pumilus GH48 in complex with cellobiose | |
| 5CVY | A8FDC4 | The Structure of Bacillus pumilus GH48 in complex with cellobiose and cellohexaose | |
| 1OGD | P36946 | The Structure of Bacillus subtilis RbsD complexed with D-ribose | |
| 1OGE | P36946 | The Structure of Bacillus subtilis RbsD complexed with Ribose 5-phosphate | |
| 5IKV | P35354 | The Structure of Flufenamic Acid Bound to Human Cyclooxygenase-2 | |
| 3N2Z | P42785 | The Structure of Human Prolylcarboxypeptidase at 2.80 Angstroms Resolution | |
| 8UDZ | P01137 | The Structure of LTBP-49247 Fab Bound to TGFbeta1 Small Latent Complex | |
| 8UDZ | 8UDZ | The Structure of LTBP-49247 Fab Bound to TGFbeta1 Small Latent Complex | |
| 6IYG | P22963 | The Structure of Maltooligosaccharide-forming Amylase from Pseudomonas saccharophila STB07 with Maltotetraose | |
| 6J3X | P22963 | The Structure of Maltooligosaccharide-forming Amylase from Pseudomonas saccharophila STB07 with Maltotriose | |
| 5IKQ | P35354 | The Structure of Meclofenamic Acid Bound to Human Cyclooxygenase-2 | |
| 5IKR | P35354 | The Structure of Mefenamic Acid Bound to Human Cyclooxygenase-2 | |
| 2C27 | O53831 | The Structure of Mycothiol Synthase in Complex with des- AcetylMycothiol and CoenzymeA. | |
| 5IKT | P35354 | The Structure of Tolfenamic Acid Bound to Human Cyclooxygenase-2 | |
| 5KIR | P35354 | The Structure of Vioxx Bound to Human COX-2 | |
| 4M56 | O06994 | The Structure of Wild-type MalL from Bacillus subtilis | |
| 2C8N | 2C8N | The Structure of a family 51 arabinofuranosidase, Araf51, from Clostridium thermocellum in complex with 1,3-linked arabinoside of xylobiose. | |
| 2C8N | Q4CJG5 | The Structure of a family 51 arabinofuranosidase, Araf51, from Clostridium thermocellum in complex with 1,3-linked arabinoside of xylobiose. |
